Rodney S. Markin's most recent trade in Cardiff Oncology Inc was a trade of 40,565 Stock Options done . Disclosure was reported to the exchange on June 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cardiff Oncology Inc | Rodney S. Markin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 40,565 | 222,865 | - | - | Stock Options | |
| Cardiff Oncology Inc | Rodney S. Markin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 29,700 | 182,027 | - | - | Stock Options | |
| Cardiff Oncology Inc | Rodney S. Markin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 27,700 | 152,327 | - | - | Stock Options | |
| Cardiff Oncology Inc | Rodney S. Markin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 26,800 | 124,627 | - | - | Stock Options | |
| Cardiff Oncology Inc | Rodney S. Markin | Director | Purchase of securities on an exchange or from another person at price $ 10.32 per share. | 26 Mar 2021 | 2,900 | 23,879 (0%) | 0% | 10.3 | 29,933 | Common Stock |